131 related articles for article (PubMed ID: 9160693)
1. High prevalence of hepatitis G virus in bone marrow transplant recipients and patients treated for acute leukemia.
Skidmore SJ; Collingham KE; Harrison P; Neilson JR; Pillay D; Milligan DW
Blood; 1997 May; 89(10):3853-6. PubMed ID: 9160693
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood.
Heuft HG; Berg T; Schreier E; Künkel U; Tacke M; Schwella N; Hopf U; Salama A; Huhn D
Vox Sang; 1998; 74(3):161-7. PubMed ID: 9595643
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C and G virus infection and liver dysfunction after allogeneic bone marrow transplantation: results from a prospective study.
Rodriguez-Iñigo E; Tomás JF; Gómez-García de Soria V; Bartolomé J; Pinilla I; Amaro MJ; Carreño V; Fernández-Rañada JM
Blood; 1997 Aug; 90(3):1326-31. PubMed ID: 9242569
[TBL] [Abstract][Full Text] [Related]
4. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.
Alter HJ; Nakatsuji Y; Melpolder J; Wages J; Wesley R; Shih JW; Kim JP
N Engl J Med; 1997 Mar; 336(11):747-54. PubMed ID: 9052652
[TBL] [Abstract][Full Text] [Related]
5. [Epidemiology of hepatitis G virus infection in Japan].
Nakatsuji Y; Tanaka E; Kiyosawa K
Nihon Rinsho; 1997 Mar; 55(3):604-8. PubMed ID: 9086766
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis G virus RNA in French blood donors and recipients.
Loiseau P; Mariotti M; Corbi C; Ravera N; Girot R; Thauvin M; Portelette E; Mariette X; Roudot-Thoraval F; Benbunan M; Lefrère JJ
Transfusion; 1997 Jun; 37(6):645-50. PubMed ID: 9191827
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, persistence and liver enzyme levels of HGV RNA-positive blood donors determined by large-scale screening and transmission by blood components.
Hitzler WE; Runkel S
Clin Lab; 2004; 50(1-2):25-31. PubMed ID: 15000218
[TBL] [Abstract][Full Text] [Related]
8. Long-term liver function of recipients with hepatitis G virus infection after bone marrow transplantation.
Maruta A; Tanabe J; Hashimoto C; Kato K; Kanamori H; Fukawa H; Miyashita H; Fujisawa S; Fujita H; Matsuzaki M; Motomura S; Kodama F; Ookawa S; Mohri H; Ishigatsubo Y
Bone Marrow Transplant; 1999 Aug; 24(4):359-63. PubMed ID: 10467323
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical features of hepatitis G virus infection in bone marrow allograft recipients.
Corbi C; Traineau R; Esperou H; Ravera N; Portelette E; Benbunan M; Gluckman E; Loiseau P
Bone Marrow Transplant; 1997 Dec; 20(11):965-8. PubMed ID: 9422476
[TBL] [Abstract][Full Text] [Related]
10. Serum hepatitis G virus (HGV) RNA in multitransfused thalassemics from eastern Sicily.
Cacopardo B; Berger A; Cosentino S; Lombardo S; Morrone ML; Boscia V; Vinci G; Restivo R; Brancati G; Doerr HW; Nunnari A
J Infect; 1998 Mar; 36(2):179-83. PubMed ID: 9570651
[TBL] [Abstract][Full Text] [Related]
11. Persistence and clinical outcome of hepatitis G virus infection in pediatric bone marrow transplant recipients and children treated for hematological malignancy.
Yamada-Osaki M; Sumazaki R; Tsuchida M; Koike K; Fukushima T; Matsui A
Blood; 1999 Jan; 93(2):721-7. PubMed ID: 9885235
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of hepatitis G virus infection in multiply transfused children with thalassaemia.
Poovorawan Y; Theamboonlers A; Chongsrisawat V; Seksarn P; Jarvis L; Simmonds P
J Gastroenterol Hepatol; 1998 Mar; 13(3):253-6. PubMed ID: 9570237
[TBL] [Abstract][Full Text] [Related]
13. High rates of hepatitis G virus infection in multitransfused patients with hemophilia.
De Filippi F; Colombo M; Rumi MG; Tradati F; Prati D; Zanella A; Mannucci PM
Blood; 1997 Dec; 90(11):4634-7. PubMed ID: 9373276
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and disease association of hepatitis G virus infection in Japan.
Nakatsuji Y; Shih JW; Tanaka E; Kiyosawa K; Wages J; Kim JP; Alter HJ
J Viral Hepat; 1996 Nov; 3(6):307-16. PubMed ID: 8947882
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and infectivity of hepatitis G virus and its strain variant, the GB agent, in volunteer blood donors in Taiwan.
Wang JT; Chen PJ; Liu DP; Sheu JC; Wang TH; Chen DS
Transfusion; 1998 Mar; 38(3):290-5. PubMed ID: 9563410
[TBL] [Abstract][Full Text] [Related]
16. Association of GB virus C (GBV-C)/hepatitis G virus (HGV) with haematological diseases of different malignant potential.
Pavlova BG; Heinz R; Selim U; Tüchler H; Pittermann E; Eder G
J Med Virol; 1999 Apr; 57(4):361-6. PubMed ID: 10089047
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis G virus does not cause significant liver disease after liver transplantation.
Karayiannis P; Brind AM; Pickering J; Mathew J; Burt AD; Hess G; Bassendine MF; Thomas HC
J Viral Hepat; 1998 Jan; 5(1):35-42. PubMed ID: 9493515
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of GB virus C/hepatitis G virus ribonucleic acid and anti-hepatitis G virus-E2 antibodies among Japanese children with histories of transfusions or with liver diseases.
Goto K; Sugiyama K; Li R; Miyake Y; Ando T; Mizutani F; Terabe K; Mizuno K; Wada Y
Pediatr Res; 1999 Jan; 45(1):128-32. PubMed ID: 9890620
[TBL] [Abstract][Full Text] [Related]
19. Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus.
Tan D; Matsumoto A; Conry-Cantilena C; Melpolder JC; Shih JW; Leuther M; Hess G; Gibble JW; Ness PM; Alter HJ
J Infect Dis; 1999 May; 179(5):1055-61. PubMed ID: 10191204
[TBL] [Abstract][Full Text] [Related]
20. TT virus and hepatitis G virus infections in Korean blood donors and patients with chronic liver disease.
Jeon MJ; Shin JH; Suh SP; Lim YC; Ryang DW
World J Gastroenterol; 2003 Apr; 9(4):741-4. PubMed ID: 12679923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
